Key Highlights

  • Revenue hit a record USD 313 million, climbing 13% from a year before, and rising 19% once a one-off Partnership benefit from 2025 is set aside.
  • The Operating Margin came in at 32.2%, and adjusted EBITDA reached USD 111 million, equal to 35.5% of sales and a 1,060 basis point improvement.
  • Diluted GAAP Earnings Per Share landed at USD 0.50, up from USD 0.10, while the adjusted figure of USD 0.53 grew 61%.
  • The company lifted 2026 Revenue expectations to a band of USD 1,143 million through USD 1,163 million and raised adjusted EPS expectations to USD 1.68 through USD 1.72.

Strong Demand Across Most Markets Powers a Peak Quarter

Cognex (NASDAQ:CGNX) closed its quarter on October 4, 2026 and disclosed the results on November 4. Sales totaled USD 313 million, against USD 277 million on a reported basis and USD 264 million once the 2025 partnership windfall is excluded. Demand was described as widespread across the bulk of key end markets, with currency exerting little influence. Gross margin widened to 70.8% from 67.6%, while the adjusted version reached 71.3% from 68.4%, supported by product mix, higher Volume and pricing that beat plans, which more than absorbed higher memory component expenses. Spending dropped 7% to USD 121 million, lifting Operating Income to USD 101 million from a reported USD 58 million.

Earnings Jump Measured Against an Inflated Base

Net income under GAAP rose to USD 85 million from USD 18 million, and the adjusted measure reached USD 90 million compared with USD 56 million. The earlier period carried a distortion from a medical lab automation partnership, so removing it lifts the adjusted EPS increase to 89% from USD 0.28. The CFO characterized adjusted EBITDA conversion as exceeding 100%, and the firm framed the period as its ninth straight stretch of rising adjusted EPS and expanding margins. The Balance Sheet holds USD 846 million in cash and investments with no borrowings. Operating cash generation was USD 106 million and free Cash Flow USD 104 million, dividends absorbed USD 14 million, and the release says free cash flow was 122% of net income. A quarterly Dividend of USD 0.09 per share, roughly 6% higher, is payable on December 3, 2026.

Forward Targets, the RealSense Purchase and Cost Pressures

Guidance for the fourth quarter sits at USD 270 million to USD 290 million in revenue, a 29% to 32% adjusted EBITDA margin and USD 0.37 to USD 0.41 adjusted EPS. The full-year adjusted EBITDA margin band has shifted to 31% to 32% from 29% to 31%. In a separate move, the company will acquire RealSense, a depth-sensing camera provider serving robotic perception and physical artificial intelligence, through an all-cash transaction set to close during the fourth quarter of 2026. Pricing for that deal is absent from the material. Investors should weigh memory component costs, the non-recurring nature of last year's partnership gain and the integration of the purchase.

Where Things Stand

The margin looks well supported for now, though the comparison flatters it. Cognex (NASDAQ:CGNX) converted 13% revenue growth into a 32.2% operating margin through pricing, mix and lower expenses, and management raised full-year guidance and its dividend. Part of the profit growth reflects a weak base, since the year-ago quarter included a partnership item. Memory costs were a headwind in the quarter, and the fourth-quarter adjusted EBITDA margin guidance of 29% to 32% sits below the third-quarter 35.5%. Next markers are the RealSense closing and fourth-quarter delivery against the guidance range.